Field Director, Medical Affairs Oncology

For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases.

Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.

Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com .

The Field Director, Medical Affairs Oncology, will serve as a scientific peer within the gynecologic oncology medical community and the broader oncology medical community. Reporting to the Vice President, Medical Affairs, the Field Director is responsible for developing and strengthening professional relationships with key opinion leaders (KOLs), professional organizations, and patient advocacy groups. This individual will lead the U.S. Medical Science Liaison (MSL) team in support of the Lifyorli® (Relacorilant) launch in platinum-resistant ovarian cancer. As a key member of the Medical Affairs Leadership Team (MALT), the Field Director will contribute to launch and development efforts, maintain fiscal responsibility, drive innovation, and ensure the successful execution of Medical Affairs strategy. The Field Director will embody the mission, vision, and values of the Medical Affairs organization and the broader Oncology Business Unit.

Responsibilities:

Model and promote Corcept’s key principles: collaborating effectively, embracing possibilities, following the data, and leading by doing, to build a culture of accountability, innovation, and trust

Demonstrate medical leadership and expertise by engaging in peer-to-peer interactions within the gynecological oncology community. Develop the KOL engagement plan. Lead the MSL plan to establish and build relationships with key opinion leaders (KOLs), professional organizations, and patient organizations

Raise awareness for the role of glucocorticoid receptor antagonism in oncology. Communicate scientific evidence related to Corcept oncology programs and advance the Corcept oncology scientific platform

Deliver clinical presentations and communicate scientific data in one-on-one interactions, at key medical and scientific congresses, and other forums

Build and lead the Medical Science Liaison team in the United States in support of the Relacorilant launch in platinum resistant ovarian cancer. Encourage the growth and personal development of each MSL to contribute to job satisfaction and to retain team members

Support field medical excellence standards, KPIs, and development frameworks

Support the development of national oncology MSL education by the MSL field team training team. Assist with onboarding, advanced scientific training, and leadership development programs for the MSL organization

Contribute to developing Medical Affairs strategies in support of the Relacorilant launch and oncology development programs

Support the MSL team’s interactions with clinical operations and clinical trial investigators to support enrollment of oncology clinical trials

Develop the plan for presence, coverage of competitive intelligence, and KOL engagement at key congresses and meetings. Mentor MSL meeting leads

Communicate insights and issues from field interactions to internal stakeholders

Support cross-functional alignment between Field Medical, Medical Communications, Clinical Development, Commercial, and Medical Operations

Maintain a deep knowledge of gynecological oncology and a broad understanding of other relevant oncology indications

Participate in the identification and publication of scientific materials

Facilitate scientific exchange within legal, compliance and regulatory guidelines

Preferred Skills, Qualifications and Technical Proficiencies:

Thorough grasp of treatment guidelines, clinical research processes, FDA regulations, and ethical guidelines as applied to the pharmaceutical industry

Strong track record of maintaining positive relationships with key stakeholders

Demonstrated leadership and ability to perform effectively in a dynamic environment

Strong interpersonal, organizational, team, written and verbal communication skills

Sound judgement in handling complex, confidential and regulated information

Launch experience preferred

Ability to travel up to 50-70%

Preferred Education and Experience:

Advanced degree in a scientific or medical discipline (PharmD, MD, MSN, PhD, etc.)

10+ years relevant Oncology experience (clinical practice, academic, and or industry), gyne/onc preferred; and at least 7 years MSL field experience in the pharmaceutical or biotech industry is preferred

Direct leadership experience is required

The pay range that the Company reasonably expects to pay for this position is $209,100 - $276,800; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.

#LI-Remote

Applicants must be currently authorized to work in the United States on a full-time basis.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link .

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

Please visit our website at: https://www.corcept.com/

Corcept is an Equal Opportunity Employer

Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.